CORONAVIRUS NEWS
Rapid antigen test and support for SARS-CoV-2 testing
Avacta Group and Mologic have entered a partnership to market Avacta’s AffiDX SARS-CoV-2 lateral-flow rapid antigen test. Avacta will also support antigen testing in low- and middle-income countries by providing access to Avacta’s spike antigen test.
The infection challenging the world: a virtual meeting in May
The British Society for Microbial Technology (BSMT) will hold a virtual conference entitled ‘COVID-19 – The Infection Challenging the World' over four days in May. Click on this story for an update on the conference programme and commercial support.
High-throughput bead-assisted mass spectrometry test for SARS-CoV-2
Avacta Group has entered into a collaboration agreement with Bruker to evaluate the Affimer-based, bead-assisted mass spectrometry (BAMS) SARS-CoV-2 assay, developed with Adeptrix.
The infection that challenged the world: a date for your diary
The British Society for Microbial Technology (BSMT) is organising a virtual conference entitled ‘COVID-19 – The Infection that Challenged the World: Is Necessity the Mother of Invention?’
Launch of SARS-CoV-2 IgG II antibody test
Beckman Coulter has launched its Access SARS-CoV-2 IgG II assay in countries accepting the CE mark. The new Access SARS-CoV-2 IgG II assay quantitatively measures a patient’s level of antibodies in response to a previous SARS-CoV-2 infection.
SARS-CoV-2 antibody test to determine previous infection
Randox Laboratories has launched its new SARS-CoV-2 IgG test, utilising patented Randox Biochip Technology to simultaneously detect IgG antibodies that are reactive to both the spike receptor binding domain (RBD) and nucleocapsid protein (NP).
Quantitative large-scale immunosequencing solution
Q2 Solutions, a global clinical trial laboratory services organisation, resulting from an IQVIA and Quest Diagnostics joint venture, has announced a partnership with Adaptive Biotechnologies, a pioneer and leader in immune-driven medicine.
Rapid antigen test receives CE mark approval
Mologic a developer of lateral-flow and rapid diagnostic technologies, has announced that its professional-use COVID-19 Rapid Antigen Test has now been certified with a CE mark.
Software update results in a faster PCR test for SARS-CoV-2
Introduction of improved software for the Vivalytic analysis device means that the CE-marked Vivalytic SARS-CoV-2 rapid coronavirus test, which uses the polymerase chain reaction (PCR), now delivers its results even faster.
Delivering ultralow-temperature freezers to vaccination centres
Scientific Laboratory Supplies (SLS) and international life sciences company Eppendorf have been chosen to provide ultralow-temperature (ULT) freezers for the country’s supply of COVID-19 vaccines.
Vitamin C: a game-changer for COVID-19 patients
Vitamin C can save the lives of those badly affected by SARS-CoV-2 infection and COVID-19 disease, and make symptoms of milder infections less severe. This is a key finding from a major review just published by senior experts from around the world.
Approval of first coronavirus vaccine: comment from BIVDA
British In Vitro Diagnostics Association (BIVDA) Chief Executive Doris-Ann Williams has welcomed the confirmation of the first COVID-19 vaccine to be approved by British regulators.
Accurate quantitative SARS-CoV-2 antibody test kit
EKF Diagnostics has introduced the Kantaro COVID-SeroKlir SARS-CoV-2 IgG antibody test kit, one of the first tests to measure precisely levels of SARS-CoV-2 neutralising antibodies in individuals.
SARS-CoV-2: testing for the infectious
In a boost to the daily testing scheme announced by the government, British firm Iceni Diagnostics has developed a solution that can identify whether or not patients are actually infectious.
SARS-CoV-2 rapid antigen test: an update
Avacta Group has announced significant progress in the development of a highly scalable manufacturing process for a lateral-flow SARS-CoV-2 antigen test, currently being carried out with BBI Solutions, and that the test shows very good sensitivity.
Whole pathogen multiplex controls for cold, cough and COVID testing
Just in time for influenza season, global diagnostics company Randox Laboratories has unveiled a range of whole pathogen multiplex controls that cover multiple viral and bacterial pathogens that cause respiratory disease.
A collaborative approach to combating SARS-CoV-2
A game-changing partnership between Randox Laboratories and Bosch Healthcare continues to change the testing landscape and capabilities both in laboratory and non-laboratory settings to rapidly detect SARS-CoV-2.
Pathogenic sample collection and transportation kit launched
EKF Diagnostics has launched a PrimeStore MTM sample collection kit. This new kit facilitates convenient and safe collection, transportation and handling of pathogenic samples, including SARS-CoV-2 and influenza.
Cameras for use with qPCR instruments testing for SARS-CoV-2
In response to global demand for dependable technologies designed to optimise coronavirus testing, Atik Cameras has developed the new VS255 and VS825 cameras for use specifically with quantitative polymerase chain reaction (qPCR) instruments
Rapid antigen testing for SARS-CoV-2 coronavirus
The Fortress COVID-19 Antigen Test, available from Una Health, is a single-use in vitro immunochromatographic assay for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal swab specimens.
Featured Supplier
The British In Vitro Diagnostics Association represents the IVD Industry in the UK, to Government, professional bodies, the public, and at MedTech Europe. Giving support to members on regulatory issues, BIVDA also promotes the clinical and cost utility of IVDs in the provision of effective healthcare, both in acute diagnosis and in the prediction...
Upcoming Events
COVID-19 - The Infection Challenging the World
Online
11-14 May 2021
Lab Innovations 2021
NEC, Birmingham
3-4 November 2021
IBMS Biomedical Science Congress 2022
International Convention Centre, Birmingham
14-17 March 2022
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store
